Clinical Trials Logo
  1. Home
  2. Intracranial Neoplasm
  3. NCT05904704

Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial Tumors

Intracranial Neoplasm Clinical Trial

Official title:
Feasibility of Oxygen Enhanced MRI in Assessment of Malignant Brain Tumors

Clinical Trial Summary

This clinical trial evaluates the feasibility of performing oxygen-enhanced magnetic resonance imaging (MRI) to generate hypoxia maps in patients with intracranial tumors. Decreased levels of oxygen (hypoxia) is a hallmark of malignant brain tumors. Chronic hypoxia is a stimulator of blood vessel formation, which is required for tumor growth and spread. Hypoxia also limits the effectiveness of radiation and chemotherapy. MRI is an imaging technique that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The administration of inhaled oxygen allows for an increased MRI signal effect size. Oxygen-enhanced MRI may be a non-invasive method that can physiologically estimate tissue hypoxia. With a better understanding of the extent of tumor hypoxia, more effective and patient-specific therapies could be devised to halt malignant tumor growth.

Clinical Trial Description

PRIMARY OBJECTIVE: I. Determine the feasibility of generating hypoxia maps from oxygen MRI. SECONDARY OBJECTIVES: I. Evaluate the association between oxygen MRI hypoxia maps generated using T2* and T1 MRI sequences. II. Evaluate the association between oxygen MRI hypoxia maps and progression free survival. OUTLINE: Patients receive supplemental oxygen while undergoing standard of care MRI. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05904704
Study type Interventional
Source OHSU Knight Cancer Institute
Contact
Status Recruiting
Phase N/A
Start date April 12, 2023
Completion date March 31, 2029
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05732896 - Comparison of Opioid Consumption During TCI Guided by NOL Index or Standard Care Undergoing Intracranial Tumor Surgery N/A
Active, not recruiting NCT04044937 - Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms Phase 2
Not yet recruiting NCT03717766 - Application of New Technologies in the Resection of Intracranial Tumors
Completed NCT05145049 - The Relationship of Anesthesia Method With Serum Lactate Level in Craniotomies
Terminated NCT03089749 - Characterization of Human Autoantibody Titers After Central Nervous System Insult
Not yet recruiting NCT05891002 - Accuracy of Robotically Assisted Cranial Biopsies
Recruiting NCT06291662 - Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing N/A
Completed NCT04302857 - Tractography Pilot Study Leipzig
Completed NCT04454268 - Intracranial Hydatid Cyst N/A
Completed NCT03076255 - Head and Neck Maskless Immobilization Device in Immobilizing Patients With Head and Neck Cancer or Intracranial Tumors Undergoing Radiation Therapy N/A
Recruiting NCT04278118 - Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study N/A
Recruiting NCT03714347 - The Effect of Cerebral Oxygenation on Postoperative Recovery in Intracranial Surgery N/A
Completed NCT03710278 - The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat)
Withdrawn NCT03091803 - QSM and Regional DCE MRI Permeability Using GOCART Technique
Completed NCT03539731 - [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers Phase 1